Skip to content

Cooperative Adenomyosis Network

A Study of Cooperative Network of Diagnosis and Treatment of Uterine Adenomyosis.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03230994
Acronym
CAN
Enrollment
5000
Registered
2017-07-27
Start date
2017-06-30
Completion date
2020-12-30
Last updated
2018-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea, Infertility, Female, Metrorrhagia, Pathology, Radiography, Ultrasonography

Keywords

adenomyosis, diagnosis, treatment, epidemiology, Complications

Brief summary

To set up a Cooperative Network by enrolling 5000 patients with Adenomyosis(AM) from multiple centers.Based on the Network platform and Database,the investigators try to explore the diagnostic strategies for AM and carry out epidemiological survey on the semeiology of AM.In addiction,the investigators expect to conduct research on the effect and the follow-up fertility outcomes of different medical or surgical treatment, the etiology of AM and endometriosis,the perspective investigation of the malignant transformation of AM ;the high-risk factors of AM,and finally propel the formation of Expert Consensus and Clinical Guidelines about AM which suitable to chinese conditions.

Detailed description

5000 women diagnosed of Adenomyosis(AM) with pathology, transvaginal ultrasonography or magnetic resonance image(MRI)will be enrolled from nationwide multicenters. The investigators would build up Network platform, and database with the registered data within 6 months. 30-month follow-up with an interval of at least once every 6 months will be done for every patient ,and update the database timely. Based on the Network platform and Database,we try to explore the diagnostic strategies for AM and carry out epidemiological survey on the semeiology of AM.In addiction,the investigators expect to conduct research on the effect and the follow-up fertility outcomes of different medical or surgical treatment,the etiology of AM and endometriosis,the perspective investigation of the malignant transformation of AM ;the high-risk factors of AM,and finally propel the formation of Expert Consensus and Clinical Guidelines about AM which suitable to chinese conditions.

Interventions

None listed

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE

Inclusion criteria

* Women diagnosed of adenomyosis by pathology, transvaginal ultrasound or MRI.

Exclusion criteria

* Refusal to join the study

Design outcomes

Primary

MeasureTime frameDescription
Therapeutic effect and Diagnostics2daySymptom Assessment

Secondary

MeasureTime frameDescription
selection of therapeutic scheme1daypharmacotherapy or surgery
vision algetic standard(VAS)2daySemeiology and evaluative criteria
Pathology1dayDiagnostic assessment
Magnetic Resonance Imaging1dayDiagnostic assessment
pictorial blood loss assessment chart(PBAC)2daySemeiology and evaluative criteria
B type ultrasound1dayDiagnostic assessment

Countries

China

Contacts

Primary ContactLei L Li, MD
lileigh@163.com139-1198-8831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026